Robert Lustig: Key Biomarkers, fasting insulin, Uric Acid and ALT Signal Metabolic Syndrome Risk
Excerpt from a YouTube talk (speaker: Robert Lustig) asserting that fasting insulin is the single most important determinant of metabolic health and naming uric acid and ALT (alanine aminotransferase) as additional key biomarkers. Lustig highlights uric acid as a mitochondrial toxin and notes ALT is a liver-function test indicative of liver fat, claiming an upper-normal threshold of 25 while typical lab reports list 40.
Questions this video answers
25
40
Chapters
More from Dr.
Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health
Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet
Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome
Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose
Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance
Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet